Login to Your Account

Base editing approach corrects beta thalassemia mutation in human embryos

By Nuala Moran
Staff Writer

Wednesday, October 11, 2017

LONDON – Scientists in China have developed a chemical method to precisely edit single bases in DNA, and they used the technique in human embryos to correct a mutation in the beta globin gene that is a major cause of inherited blood disorder beta thalassemia.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription